Filter
1144
Filtered Results: 1144
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
110
New Publications
283
Language
Document type
No document type
517
Studies & Reports
241
Guidelines
197
Manuals
80
Strategic & Response Plan
60
Fact sheets
20
Training Material
14
Situation Updates
8
Brochures
3
Resource Platforms
3
Infographics
1
Countries / Regions
Global
53
India
44
Kenya
40
Western and Central Europe
31
Ethiopia
28
Nigeria
25
Ghana
18
South Africa
18
Sierra Leone
15
Uganda
15
Ukraine
14
Zimbabwe
14
Bangladesh
14
Nepal
13
Malawi
13
Philippines
13
Rwanda
12
Africa
12
Tanzania
12
Eastern Europe
12
Zambia
12
Latin America and the Carribbean
11
South–East Asia Region
10
Namibia
10
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Syria
7
Indonesia
7
Liberia
7
Myanmar / Burma
7
West and Central Africa
6
Botswana
6
Thailand
5
East and Southern Africa
5
Senegal
4
Cambodia
4
Burkina Faso
3
USA
3
Haiti
3
Asia
3
Middle East and North Africa
3
Western Pacific Region
3
Egypt
3
North Macedonia
2
Serbia
2
Lesotho
2
Benin
2
China
2
Cameroon
2
Albania
2
Laos
2
Kyrgyzstan
2
Jordan
2
Germany
2
Congo, Democratic Republic of
2
North America
2
Jamaica
2
United Kingdom
2
Lebanon
2
Vietnam
2
Russia
2
Sudan
2
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Chile
1
Iran
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Mongolia
1
Bulgaria
1
Guinea
1
Mozambique
1
Armenia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Maldives
1
Papua New Guinea
1
Moldova
1
Georgia
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
382
Clinical Guidelines
107
Public Health
68
Key Resources
59
Women & Child Health
39
Pharmacy & Technologies
35
Capacity Building
8
Toolboxes
AMR
137
Pharmacy
133
COVID-19
81
TB
57
Mental Health
55
HIV
53
Rapid Response
48
NTDs
33
Planetary Health
27
Caregiver
26
Global Health Education
25
NCDs
22
Conflict
22
Health Financing Toolbox
20
Specific Hazards
12
Ebola & Marburg
10
Polio
8
Refugee
7
Disability
7
Natural Hazards
4
Zika
2
Cholera
1
Social Ethics
1
Procedures Manual - Medicines registration in Madagascar - 2016 version
The aim of the pandemic preparedness checklist is primarily to provide an outline of the essential minimum elements of preparedness, as well as elements of preparedness that are considered desirable. It is recommended that responsible authorities or institutes in countries that are in the process of...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and of reform and policy initiatives in progress or under development in a specific country.
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re...
This document should be used in conjunction with the WHO checklist for influenza preparedness planning published by the World Health Organization in 2005. Available in English; Chinese; French
16-17 march 2015, Geneva, Switzerland
Meeting report
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by the World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-2020 period, recommended strategies, guiding princi...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Public Health Factsheet
Accessed: 29.09.2019
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
